Responses
Psoriatic arthritis
Original research
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study
Compose a Response to This Article
Other responses
No responses have been published for this article.